Subscribe to our Newsletters !!

    Research

    Scientists foster new device to assist with giving early warning of uncommon and unknown virus

    McMaster University researchers have created a new tool that can help identify deadly bacteria pathogens and early warning signs of unknown viruses. This algorithm can be used to develop advanced probes that capture trace amounts of pathogens from a variety of situations such as the animal-to human transmission of infections like SARS-CoV-2, or monitor environmental

    Researchers move forward in the development of microbial fuel cells

    A UCLA-led group of engineers and chemists have taken an important step in the creation of fuel cells made by microbial organisms which is a method that makes use of natural bacteria to pull electrons out of organic material within the water to create electrical currents. A research paper detailing the groundbreaking technology was published

    Scientists find how Rift Valley fever virus enters cells

    Rift Valley fever virus causes economically tragic hemorrhagic outbreaks in livestock, including cattle, goats, and sheep. The mosquito-borne infections can lead to the spread of infection to people who work with animals that are dying or dead often causing many human infections as well as many deaths. Rift Valley fever, for which there isn’t a

    Small molecule drug can weaken the triggers of neuroinflammation, preclinical review shows

    Neuroinflammation may cause worse outcomes in cases of stroke, injuries to the brain or injury, and can increase the severity of neurodegenerative diseases such as ALS, Parkinson’s, or Alzheimer’s. This suggests that reducing neuroinflammation might be an exciting new method to treat neurological disorders and neuropathic pain caused by neuroinflammation. In a preclinical study ,

    Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations

    Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit

    Dietary components hold guarantee for working on the health and wellbeing of grown-ups

    Research suggests that nutritional supplements that target specific mechanisms that are associated with age-associated cellular decay (AACD), have the potential to improve health and well-being for adults. “Cellular Nutrition and Its Influence on Age-Associated Cellular Decline,” the latest issue of The Gerontological Society of America’s What’s Hot newsletter with accompanying infographic, provides an overview of

    Inhalation Research Services chosen for new research project worth 1.45 million SEK by US pharma company

    (Stockholm 18 July 2022) A US company with an extensive pipeline in medical dermatology has chosen Inhalation Research Services (IRS), ISAB’s contract research organization, for a research project worth 1.45 million SEK (1.36 K Euro) into a new repurposed drug that is being reformulated for administration via the lungs. ISAB’s world-class expertise in inhalation, and